Method | AUROC | AUPRC | AUKC | Precision | Sensitivity | Kappa | F1 score |
---|---|---|---|---|---|---|---|
End-point: Unanticipated ICU admissions | |||||||
LR | 83.4% (2.7%) | 5.1% (1.9%) | 2.1% (0.3%) | 8.9% (4.4%) | 12.5% (6.9%) | 0.10 (0.05) | 10.3% (5.2%) |
LR (Combined)a | 82.1% (3.1%) | 5.1% (1.8%) | 2.1% (0.3%) | 9.0% (3.4%) | 12.5% (5.3%) | 0.10 (0.04) | 10.3% (4.0%) |
End-point: In-hospital mortality | |||||||
LR | 91.8% (2.9%) | 6.4% (3.4%) | 1.6% (0.4%) | 7.0% (3.1%) | 26.8% (11.8%) | 0.11 (0.05) | 11.0% (4.7%) |
LR (Combined)a | 89.5% (3.2%) | 4.9% (4.3%) | 1.3% (0.3%) | 5.9% (2.8%) | 22.4% (11.0%) | 0.09 (0.04) | 9.2% (4.3%) |
End-point: Unanticipated ICU admissions & in-hospital mortality | |||||||
LR | 83.5% (2.8%) | 7.2% (2.8%) | 2.6% (0.3%) | 12.2% (4.2%) | 13.5% (5.4%) | 0.12 (0.05) | 12.8% (4.6%) |
LR (Ensemble)b | 84.5% (2.8%) | 7.0% (2.6%) | 2.7% (0.3%) | 11.4% (4.2%) | 12.7% (5.8%) | 0.11 (0.05) | 11.9% (5.2%) |
SVM | 82.8% (2.9%) | 5.5% (2.2%) | 2.4% (0.3%) | 8.4% (4.4%) | 8.8% (4.7%) | 0.08 (0.04) | 8.4% (4.3%) |
XGB | 79.7% (3.9%) | 5.7% (2.6%) | 2.2% (0.4%) | 10.9% (5.5%) | 8.5% (4.6%) | 0.09 (0.05) | 9.4% (4.8%) |
RF | 81.4% (2.8%) | 5.1% (1.4%) | 2.3% (0.3%) | 9.5% (7.0%) | 4.0% (3.5%) | 0.05 (0.04) | 5.1% (3.7%) |